AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 APR 12 - (NewsRx.com & NewsRx.net) -- Use of estrogen replacement therapy (ERT), with or without progestins, among women diagnosed with endometrial cancer does not appear to increase their risk of recurring cancer or death, says new research from the University of California Irvine.
ERT for women with a history of endometrial cancer remains controversial. Physicians have historically withheld ERT from these patients ...